Kerala’s Senior Citizens Care Bill, 2026, introduces enforceable standards for geriatric care, regulates elderly care facilities, recognizes living wills, and strengthens protection against abuse.
Zydus' Keytruda biosimilar FYB206 enters FDA review without a comparative Phase III efficacy trial, highlighting a shift in biosimilar development.
Karnataka introduces transparent medicine pricing details on hospital bills from November 1, helping patients compare procurement costs, MRP and final charges.
Drug testing laboratories in India face capacity constraints as regulators retain existing testing timelines and promote stronger infrastructure and digital oversight.
Global health is entering a critical reset as India expands digital mental health support, launches high-altitude medical research, and Roche calls for a healthcare overhaul to tackle the growing burden of non-communicable diseases.
The FDA’s latest actions bring new hope for cancer and herpes treatment while product recalls raise fresh concerns about drug safety and quality.
The Thyrocare Madurai lab strengthens regional healthcare infrastructure by expanding access to routine and specialised diagnostic testing across southern Tamil Nadu.
Dr Reddy's received two USFDA observations at its Andhra Pradesh facility, highlighting the importance of Indian pharma GMP compliance and manufacturing quality.
AIIMS Bathinda HIPEC unit expands specialised peritoneal cancer treatment and strengthens advanced cancer-care access across Punjab and neighbouring states.
Novartis Rhapsido FDA approval adds the first targeted treatment for symptomatic dermographism, addressing persistent symptoms despite H1 antihistamines.
.jpg)
, CDSCO.jpg)
